about
Curcumin AntiCancer Studies in Pancreatic CancerRadio-frequency ablation-based studies on VX2rabbit models for HCC treatment.Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studiesThe Therapeutic Targets of miRNA in Hepatic Cancer Stem CellsThe Role of miRNAs in the Regulation of Pancreatic Cancer Stem CellsGene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinomaRadiological assessment of anal cancer: an overview and updateMultidetector computer tomography in the pancreatic adenocarcinoma assessment: an updateHepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in ItalyThe Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesInduction of VX2 para-renal carcinoma in rabbits: generation of animal model for loco-regional treatments of solid tumors.Hepatocellular carcinoma and liver metastases: clinical data on a new dual-lumen catheter kit for surgical sealant infusion to prevent perihepatic bleeding and dissemination of cancer cells following biopsy and loco-regional treatments.Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors.Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update.Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases.Food groups and risk of hepatocellular carcinoma: A multicenter case-control study in Italy.Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancerHepatocellular carcinoma: preclinical data on a dual-lumen catheter kit for fibrin sealant infusion following loco-regional treatments.Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer ProgressionSurgical treatment of colorectal cancer metastasis.BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy.CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does notEarly Assessment of Colorectal Cancer Patients with Liver Metastases Treated with Antiangiogenic Drugs: The Role of Intravoxel Incoherent Motion in Diffusion-Weighted Imaging.Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).Metabolic syndrome and hepatocellular carcinoma riskMolecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.Decrease of survivin, p53 and Bcl-2 expression in chemorefractory colorectal liver metastases may be predictive of radiosensivity radiosensivity after radioembolization with yttrium-90 resin microspheresNeoadjuvant FOLFIRI+bevacizumab in patients with resectable liver metastases from colorectal cancer: a phase 2 trial.Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 ExaminationsMolecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Prospective screening increases the detection of potentially curable hepatocellular carcinoma: results in 8,900 high-risk patients.HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.Management of colorectal liver metastases in patients with peritoneal carcinomatosis.HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.
P50
Q26738714-6E477E50-C3C5-4C27-A212-DB5254AB9C6EQ26741499-EA0C95C4-79E2-4DF9-9468-EBD15CFBAE6FQ26749111-53040B11-A5CD-4621-8095-61C1763EB7FBQ26749450-7A468C69-38FE-4C14-A256-69D8EE834235Q26752473-C19C76DF-98C5-4E83-A876-E8CD4C30F058Q27490242-7E3AB2B5-39DB-470E-B181-C7B056E1628AQ28079785-AAE38ED8-EF1E-4669-AF9A-FBCE6F177D75Q28079879-71DC5191-FD5D-48D7-AAF2-CC5E43EE1260Q28307124-D1151ABC-91E6-4A2C-86E3-600F51F7B31CQ28546913-6BEAAC94-8AB7-46F6-844E-58BF159468D5Q30367899-7E54ED04-98F5-414A-AEAA-481083BD009EQ30937758-0A55DA26-CEE5-4DCF-A233-40EB65B979F9Q31145081-D6B027C6-70CE-4E0A-9766-1F8E9D88A3ECQ33372476-41CBA78E-CB4F-4F91-A805-B09C2CD22CF2Q33617869-2713E3CD-BC38-47DD-9971-905434920AABQ33618547-CE20EAED-7CBE-4813-B8D7-009AC2973958Q33817430-0C0A0275-CD8D-4BA6-BC7D-674EB078D7AEQ34059726-366E4291-5BF6-47DE-AD25-8039E59F58C8Q34568627-C8C7411C-7E73-4F8D-9576-2342C05BD0BEQ35107234-586C74CA-E397-4B9C-808F-E34249356915Q35206102-D24599A6-167C-4A40-9BDE-2D7C22D80F1AQ35281792-CE8A2E78-860F-4DEE-8413-DBC604860460Q35502388-75AD3A37-A113-431F-8C83-440AE833FB6BQ35612450-CADB583C-2A0A-4E81-B035-900B680A1475Q35682117-5DDDB60D-FBAF-4749-8141-F6FC0F9CA2B7Q35723888-12A22CA6-BC98-47BD-9EE6-0ADFEDB7AF72Q35833601-834AB0C5-C0B0-4896-8250-1B9A4F9F1AD7Q35840971-0B975D70-0AD5-442B-9738-D0EB36C16584Q35879571-AE9D2802-9EC7-40B1-966E-74FD6120670DQ35917810-E5BE0EA7-CF18-43AB-88C2-5307DA906043Q36557772-D919ADEA-DA85-416F-A749-72E7A88443FAQ36618666-F097E546-49E4-4024-B0F7-1896F824B438Q36697911-96688CF0-CF92-4B39-80E0-AD6F28D17F51Q36889705-7EDDF23D-E54E-4FD3-AA41-63C93F76C173Q37250096-1C495D52-74F0-467D-AE49-C5FB404075F1Q37295260-D6FA0C2A-D975-466A-A8C1-148752BA6A5BQ37350320-77EE40D7-4D02-4952-AA31-CF93B4FCC837Q37437190-AFA940BC-6740-4C7F-ADD9-045B59827AADQ37583772-31936E59-DD81-4A33-821D-F650A8E7378FQ37632065-A2068900-2783-43B6-A018-51BA3409CA21
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesco Izzo
@ast
Francesco Izzo
@en
Francesco Izzo
@es
Francesco Izzo
@nl
Francesco Izzo
@sl
type
label
Francesco Izzo
@ast
Francesco Izzo
@en
Francesco Izzo
@es
Francesco Izzo
@nl
Francesco Izzo
@sl
prefLabel
Francesco Izzo
@ast
Francesco Izzo
@en
Francesco Izzo
@es
Francesco Izzo
@nl
Francesco Izzo
@sl
P1053
K-5261-2016
P106
P1153
23046697900
7004328114
P21
P31
P3829
P496
0000-0003-3093-5408